Hisato Inatomi

1.3k total citations
34 papers, 887 citations indexed

About

Hisato Inatomi is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hisato Inatomi has authored 34 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hisato Inatomi's work include Glutathione Transferases and Polymorphisms (9 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Hisato Inatomi is often cited by papers focused on Glutathione Transferases and Polymorphisms (9 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Hisato Inatomi collaborates with scholars based in Japan, United States and Sri Lanka. Hisato Inatomi's co-authors include Tetsuro Matsumoto, Takahiko Katoh, Toshihiro Kawamoto, Tetsuro Muratani, Takashi Hamasaki, Yoji Yamada, Mihi Yang, Douglas A. Bell, Hirohisa Imai and Akira Nagaoka and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Urology and International Journal of Cancer.

In The Last Decade

Hisato Inatomi

34 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hisato Inatomi Japan 18 526 184 139 132 97 34 887
Yoo‐Kyung Lee South Korea 16 178 0.3× 98 0.5× 12 0.1× 64 0.5× 95 1.0× 32 707
Takeshi Takagi Japan 12 437 0.8× 88 0.5× 10 0.1× 396 3.0× 44 0.5× 49 814
Jennifer W. Harris United States 13 395 0.8× 187 1.0× 18 0.1× 360 2.7× 91 0.9× 22 851
John M. Benditt United States 3 224 0.4× 124 0.7× 10 0.1× 128 1.0× 50 0.5× 4 682
Stefanos Zervoudis Greece 11 134 0.3× 83 0.5× 13 0.1× 166 1.3× 60 0.6× 55 665
Susanne Haas Germany 14 184 0.3× 53 0.3× 22 0.2× 70 0.5× 37 0.4× 23 429
K Noda Japan 15 150 0.3× 171 0.9× 16 0.1× 43 0.3× 123 1.3× 45 636
Mohammad Arafa Egypt 14 223 0.4× 94 0.5× 6 0.0× 128 1.0× 50 0.5× 45 589
B. Fournier France 10 254 0.5× 252 1.4× 7 0.1× 25 0.2× 41 0.4× 44 583
Kathryn A. Maurer United States 12 120 0.2× 68 0.4× 12 0.1× 92 0.7× 28 0.3× 24 548

Countries citing papers authored by Hisato Inatomi

Since Specialization
Citations

This map shows the geographic impact of Hisato Inatomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisato Inatomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisato Inatomi more than expected).

Fields of papers citing papers by Hisato Inatomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisato Inatomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisato Inatomi. The network helps show where Hisato Inatomi may publish in the future.

Co-authorship network of co-authors of Hisato Inatomi

This figure shows the co-authorship network connecting the top 25 collaborators of Hisato Inatomi. A scholar is included among the top collaborators of Hisato Inatomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisato Inatomi. Hisato Inatomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomisaki, Ikko, et al.. (2021). Combination therapy with paclitaxel and gemcitabine after platinum‐based chemotherapy in patients with advanced urothelial cancer. International Journal of Urology. 28(9). 970–974. 6 indexed citations
2.
Muratani, Tetsuro, et al.. (2008). Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae. International Journal of Urology. 15(9). 837–842. 24 indexed citations
3.
Nakao, Hiroyuki, Yusuke Kuroda, Hirohisa Imai, et al.. (2004). Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking. European Journal of Cancer Prevention. 13(6). 509–514. 15 indexed citations
4.
Tsukino, Hiromasa, Yoshiki Kuroda, Hiroyuki Nakao, et al.. (2004). Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. Journal of Cancer Research and Clinical Oncology. 130(2). 99–106. 28 indexed citations
5.
Tsukino, Hiromasa, Yoshiki Kuroda, Hirohisa Imai, et al.. (2004). Lack of Evidence for the Association of <i>E-Cadherin</i> Gene Polymorphism with Increased Risk or Progression of Prostate Cancer. Urologia Internationalis. 72(3). 203–207. 25 indexed citations
6.
Tsukino, Hiromasa, Yoshiki Kuroda, Hiroyuki Nakao, et al.. (2003). E-cadherin gene polymorphism and risk of urothelial cancer. Cancer Letters. 195(1). 53–58. 33 indexed citations
7.
Hamasaki, Takashi, et al.. (2003). N‐acetyltransferase‐2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men. International Journal of Urology. 10(3). 167–173. 37 indexed citations
8.
Hamasaki, Takashi, et al.. (2002). Significance of Vitamin D Receptor Gene Polymorphism for Risk and Disease Severity of Prostate Cancer and Benign Prostatic Hyperplasia in Japanese. Urologia Internationalis. 68(4). 226–231. 32 indexed citations
9.
Muratani, Tetsuro, Hisato Inatomi, Naohiro Fujimoto, et al.. (2002). Faropenem 300mg 3 Times Daily Versus Levofloxacin 100mg 3 Times Daily in the Treatment of Urinary Tract Infections in Patients with Neurogenic Bladder and/or Benign Prostatic Hypertrophy. Kansenshogaku zasshi. 76(11). 928–938. 5 indexed citations
10.
Muratani, Tetsuro, Tomoko Kobayashi, Yoji Yamada, et al.. (2001). Outbreak of Cefozopran (Penicillin, Oral Cephems, and Aztreonam)-Resistant Neisseria gonorrhoeae in Japan. Antimicrobial Agents and Chemotherapy. 45(12). 3603–3606. 65 indexed citations
11.
Muratani, Tetsuro, et al.. (2001). Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce β-lactamase. Journal of Infection and Chemotherapy. 7(1). 49–50. 55 indexed citations
12.
Hamasaki, Takashi, et al.. (2001). Diagnosis of Retrovesical Ectopic and Hyperplastic Prostate Tissue by Transrectal Needle Biopsy. Urologia Internationalis. 66(3). 171–173. 5 indexed citations
13.
Katoh, Takahiko, Hisato Inatomi, Mihi Yang, et al.. (1999). Arylaminc N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese. Pharmacogenetics. 9(3). 401–404. 67 indexed citations
14.
Inatomi, Hisato, Takahiko Katoh, Toshihiro Kawamoto, & Tetsuro Matsumoto. (1999). NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese. International Journal of Urology. 6(9). 446–454. 40 indexed citations
15.
Sato, Hideki, et al.. (1999). Results of conservative treatment of upper urinary tract transitional cell carcinoma. International Journal of Urology. 6(8). 381–387. 6 indexed citations
16.
Katoh, Takahiko, Hisato Inatomi, Heon Kim, et al.. (1998). Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Letters. 132(1-2). 147–152. 72 indexed citations
17.
Inatomi, Hisato, et al.. (1996). A Case of Prostate Carcinoma Metastasizing to Renal Cell Carcinoma. International Journal of Urology. 3(2). 155–157. 13 indexed citations
18.
Hamasaki, Takashi, et al.. (1996). Clinical Study of Occupational Uroepithelial Cancer. Journal of UOEH. 18(4). 247–259. 1 indexed citations
19.
Katoh, Takahiko, et al.. (1995). Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis. 16(3). 655–657. 66 indexed citations
20.
Koda, Yoshiro, Yasuhito Uezono, Hideyuki Kobayashi, et al.. (1991). Protein kinase C in human pheochromocytoma. Neuroscience Letters. 127(1). 31–33. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoo‐Kyung Lee Breakdown of academic impact, for papers by Takeshi Takagi Breakdown of academic impact, for papers by Jennifer W. Harris Breakdown of academic impact, for papers by John M. Benditt Breakdown of academic impact, for papers by Stefanos Zervoudis Breakdown of academic impact, for papers by Susanne Haas Breakdown of academic impact, for papers by K Noda Breakdown of academic impact, for papers by Mohammad Arafa Breakdown of academic impact, for papers by B. Fournier Breakdown of academic impact, for papers by Kathryn A. Maurer
Rankless by CCL
2026